INA-RESPOND has several strategic strengths that position it as a key infectious disease clinical research platform in Indonesia.
STRATEGIC STRENGTHS OF INA-RESPOND
01
National Clinical Research Network
INA-RESPOND coordinates a network of hospitals and research institutions enabling multicenter clinical studies across Indonesia.
02
Strong International Partnerships
As a bilateral partnership between the Governments of Indonesia and the United States, INA-RESPOND facilitates scientific collaboration between national and international researchers.
03
Reference Laboratory With Advanced Diagnostic Capacity
The INA-RESPOND Reference Laboratory supports infectious disease research through advanced diagnostic capabilities, specimen processing, and outbreak investigation support.
04
Experience in Multicenter Clinical Research
INA-RESPOND has extensive experience conducting observational and interventional studies, including international clinical trials involving multiple research sites.
05
Strengthening National Research Capacity
Through training, development of standard operating procedures, and strengthening research management systems, INA-RESPOND contributes to improving clinical research capacity in Indonesia.
© Copyright - Ina-Respond. 2022